82 related articles for article (PubMed ID: 2426566)
1. [Chronology of recurrent gastric cancer].
Takahashi Y; Mai M; Ogino T; Ueda H; Ueno M; Kusama S
Nihon Geka Gakkai Zasshi; 1986 Jun; 87(6):604-7. PubMed ID: 2426566
[TBL] [Abstract][Full Text] [Related]
2. [Serum carcinoembryonic antigen doubling time in patients with recurrent gastrointestinal carcinoma and its relationship to tumor biology and life expectancy].
Takesue F; Inutsuka S; Nagahama S; Kusumoto H; Korenaga D; Maekawa S; Ikeda T
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():464-8. PubMed ID: 9589054
[TBL] [Abstract][Full Text] [Related]
3. [Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9].
Takahashi Y; Mai M
Gan To Kagaku Ryoho; 1992 Apr; 19(4):515-8. PubMed ID: 1558402
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
[TBL] [Abstract][Full Text] [Related]
5. [Study of CEA doubling time in liver metastasis from colonic cancer and postoperative survival time].
Takahashi Y; Kusama S; Mai M; Ueno M; Ogino T; Ueda H; Sawaguchi K
Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1422-5. PubMed ID: 3785131
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients.
Maehara Y; Tomisaki S; Oda S; Sakaguchi Y; Ichiyoshi Y; Sugimachi K
Anticancer Res; 1994; 14(6B):2755-7. PubMed ID: 7872713
[TBL] [Abstract][Full Text] [Related]
7. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
[TBL] [Abstract][Full Text] [Related]
8. [The growth rate as a parameter of degree of biological malignancy and prediction of metastasis by tumor marker doubling and half time].
Takahashi Y; Mai M; Kasama S
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1074-7. PubMed ID: 1944157
[TBL] [Abstract][Full Text] [Related]
9. [An autopsy case of a gastric cancer associated with elevated AFP, CEA and CA19-9].
Nakamura Y; Hozumi T; Ohkita M; Masuda S; Maeda M; Okada K; Chinzei T; Yamashiro K; Harui M; Hosokawa I
Gan No Rinsho; 1988 Feb; 34(2):213-8. PubMed ID: 2450214
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
12. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis.
Ono M; Sakamoto M; Ino Y; Moriya Y; Sugihara K; Muto T; Hirohashi S
Cancer; 1996 Sep; 78(6):1179-86. PubMed ID: 8826938
[TBL] [Abstract][Full Text] [Related]
13. Surgical management for metastatic liver tumors.
Hirai I; Kimura W; Fuse A; Isobe H; Hachiya O; Moriya T; Suto K; Mizutani M
Hepatogastroenterology; 2006; 53(71):757-63. PubMed ID: 17086883
[TBL] [Abstract][Full Text] [Related]
14. [The metastatic patterns of gastric cancer from its histopathological characteristics in the primary lesion--particularly in relation to peritoneal dissemination and liver metastases].
Takahashi Y; Mai M; Ogino T; Ueda H; Kitamura T; Sawaguchi K; Ueno M; Minami S
Gan No Rinsho; 1985 Nov; 31(14):1792-6. PubMed ID: 4087385
[TBL] [Abstract][Full Text] [Related]
15. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers.
Chang YC; Nagasue N; Abe S; Taniura H; Kumar DD; Nakamura T
Am J Gastroenterol; 1992 Mar; 87(3):321-5. PubMed ID: 1371637
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of the quantitative carcinoembryonic antigen and cytokeratin 20 mRNA detection in peritoneal washes to predict peritoneal recurrence in gastric carcinoma patients.
Tamura N; Iinuma H; Takada T
Oncol Rep; 2007 Mar; 17(3):667-72. PubMed ID: 17273749
[TBL] [Abstract][Full Text] [Related]
17. Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer.
Ikeda Y; Mori M; Kajiyama K; Kamakura T; Maehara Y; Haraguchi Y; Sugimachi K
Hepatogastroenterology; 1996; 43(11):1281-7. PubMed ID: 8908563
[TBL] [Abstract][Full Text] [Related]
18. [Study on association between the expression of galectin- 3 and the peritoneal metastasis in gastric cancer].
Yang ZM; Wu XT; He T; Da MX; Luo T; Qian K
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Mar; 8(2):151-4. PubMed ID: 16155829
[TBL] [Abstract][Full Text] [Related]
19. [Prediction of recurrence of gastrointestinal cancer from standpoint of biological malignancies--tumor marker doubling time and its a half life period line].
Mai M; Takahashi Y
Hum Cell; 1993 Jun; 6(2):82-7. PubMed ID: 7692953
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of tumor markers in patients with colorectal cancer].
Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
